These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10906133)

  • 1. A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2.
    Boyd MT; Vlatkovic N; Haines DS
    J Biol Chem; 2000 Oct; 275(41):31883-90. PubMed ID: 10906133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
    Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
    Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RB regulates the stability and the apoptotic function of p53 via MDM2.
    Hsieh JK; Chan FS; O'Connor DJ; Mittnacht S; Zhong S; Lu X
    Mol Cell; 1999 Feb; 3(2):181-93. PubMed ID: 10078201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
    Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
    Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
    [No Abstract]   [Full Text] [Related]  

  • 8. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.
    Böttger A; Böttger V; Sparks A; Liu WL; Howard SF; Lane DP
    Curr Biol; 1997 Nov; 7(11):860-9. PubMed ID: 9382809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
    Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
    J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-independent role of MDM2 in TGF-beta1 resistance.
    Sun P; Dong P; Dai K; Hannon GJ; Beach D
    Science; 1998 Dec; 282(5397):2270-2. PubMed ID: 9856953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the RING finger domain of MDM2 to cell cycle progression.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
    Dai MS; Sun XX; Lu H
    Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of p53-mediated G1 arrest with induction of MDM2 in sterigmatocystin-treated cells.
    Xie TX; Misumi J; Aoki K; Zhao WY; Liu SY
    Int J Oncol; 2000 Oct; 17(4):737-42. PubMed ID: 10995885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The loss of mdm2 induces p53-mediated apoptosis.
    de Rozieres S; Maya R; Oren M; Lozano G
    Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 binding protein, a novel metastasis suppressor.
    Iwakuma T; Agarwal N
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):633-40. PubMed ID: 22684342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.
    Wasylyk C; Salvi R; Argentini M; Dureuil C; Delumeau I; Abecassis J; Debussche L; Wasylyk B
    Oncogene; 1999 Mar; 18(11):1921-34. PubMed ID: 10208414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.
    Ichimura K; Bolin MB; Goike HM; Schmidt EE; Moshref A; Collins VP
    Cancer Res; 2000 Jan; 60(2):417-24. PubMed ID: 10667596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.